Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.5B | 6.0B | 3.1B | 5.2B |
| Cost of revenue | 8.2B | 5.3B | 3.4B | 5.4B |
| Gross profit | 296.3M | 635.3M | -240.0M | -201.5M |
| Operating expense | ||||
| Research & development | 475.1M | 524.6M | 633.7M | 636.1M |
| Selling general and admin | 602.6M | 608.3M | 485.2M | 953.8M |
| Other operating expenses | 281.3M | 160.8M | 131.2M | -20.5M |
| Operating income | -2.3B | -2.0B | -2.7B | -3.1B |
| Non operating interest income | ||||
| Income | 84.4M | 110.5M | 178.3M | 20.2M |
| Expense | 503.7M | 520.6M | 755.3M | 703.5M |
| Other income expense | — | — | — | — |
| Pretax income | -2.0B | -6.7B | -4.4B | -5.7B |
| Tax provision | -36.3M | -410.3M | -280.8M | 17.7M |
| Net income | -2.0B | -6.3B | -4.1B | -5.7B |
| Basic EPS | -43 | — | -107 | -199 |
| Diluted EPS | -43 | — | -107 | -199 |
| Basic average shares | — | — | 38.5M | 28.7M |
| Diluted average shares | — | — | 38.5M | 28.7M |
| EBITDA | -1.0B | -2.9B | -1.9B | -4.2B |
| Net income from continuing op. | -2.0B | -6.3B | -4.1B | -5.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |